Author: Norman F. Billups
Publisher: Facts and Comparisons
ISBN: 9781574390414
Category :
Languages : en
Pages : 0
Book Description
American Drug Index lists drag names in a time-saving dictionary style. This directory contains more than 22,000 Rx and OTC products, with cross-indexing of trade names, genetics and drug classes. ADI entries also include manufacturer, pronunciation, active ingredients, doseforms, strengths, packaging and uses. Comprehensive index includes a listing of drags which should not be crushed or chewed, drug names that look-alike or sound alike, storage requirements for USP drugs, trademark glossary and normal laboratory values, along with several other tables of hard-to find information.
The American Disease
Author: David F. Musto
Publisher: Oxford University Press, USA
ISBN: 0195125096
Category : Medical
Languages : en
Pages : 431
Book Description
The American Disease is a classic study of the development of drug laws in the United States. Supporting the theory that Americans' attitudes toward drugs have followed a cyclic pattern of tolerance and restraint, author David F. Musto examines the relationz between public outcry and the creation of prohibitive drug laws from the end of the Civil War up to the present. Originally published in 1973, and then in an expanded edition in 1987, this third edition contains a new chapter and preface that both address the renewed debate on policy and drug legislation from the end of the Reagan administration to the current Clinton administration. Here, Musto thoroughly investigates how our nation has dealt with such issues as the controversies over prevention programs and mandatory minimum sentencing, the catastrophe of the crack epidemic, the fear of a heroin revival, and the continued debate over the legalization of marijuana.
Publisher: Oxford University Press, USA
ISBN: 0195125096
Category : Medical
Languages : en
Pages : 431
Book Description
The American Disease is a classic study of the development of drug laws in the United States. Supporting the theory that Americans' attitudes toward drugs have followed a cyclic pattern of tolerance and restraint, author David F. Musto examines the relationz between public outcry and the creation of prohibitive drug laws from the end of the Civil War up to the present. Originally published in 1973, and then in an expanded edition in 1987, this third edition contains a new chapter and preface that both address the renewed debate on policy and drug legislation from the end of the Reagan administration to the current Clinton administration. Here, Musto thoroughly investigates how our nation has dealt with such issues as the controversies over prevention programs and mandatory minimum sentencing, the catastrophe of the crack epidemic, the fear of a heroin revival, and the continued debate over the legalization of marijuana.
American Drug Index 1999
Author: Norman F. Billups
Publisher: Facts and Comparisons
ISBN: 9781574390414
Category :
Languages : en
Pages : 0
Book Description
American Drug Index lists drag names in a time-saving dictionary style. This directory contains more than 22,000 Rx and OTC products, with cross-indexing of trade names, genetics and drug classes. ADI entries also include manufacturer, pronunciation, active ingredients, doseforms, strengths, packaging and uses. Comprehensive index includes a listing of drags which should not be crushed or chewed, drug names that look-alike or sound alike, storage requirements for USP drugs, trademark glossary and normal laboratory values, along with several other tables of hard-to find information.
Publisher: Facts and Comparisons
ISBN: 9781574390414
Category :
Languages : en
Pages : 0
Book Description
American Drug Index lists drag names in a time-saving dictionary style. This directory contains more than 22,000 Rx and OTC products, with cross-indexing of trade names, genetics and drug classes. ADI entries also include manufacturer, pronunciation, active ingredients, doseforms, strengths, packaging and uses. Comprehensive index includes a listing of drags which should not be crushed or chewed, drug names that look-alike or sound alike, storage requirements for USP drugs, trademark glossary and normal laboratory values, along with several other tables of hard-to find information.
United States and International Drug Control, 1909-1997
Author: David R. Bewley-Taylor
Publisher: A&C Black
ISBN: 9780826458131
Category : Political Science
Languages : en
Pages : 264
Book Description
The United States and International Drug Control, 1909-1997 charts the US quest to internationalize the doctrine of drug prohibition. The study reveals the origins, motivation and methodologies as well as the recurring contradictions and inconsistencies present within the US overseas fight against the production, manufacture, trafficking and use of certain psychoactive substances. Drawing on extensive historical materials, David Bewley-Taylor uses the international career of America's first Drug Czar, Harry J. Anslinger, to explore how the US successfully exploited hegemonic superiority in 1945 to influence the philosophy of the multilateral drug control system operated by the United Nations.More than a purely historical study, the book employs an interdisciplinary approach to understanding the development, perpetuation and consequences of a US driven multilateral drug control system. Examining the contemporary UN drug control framework, the author argues that international legislation is largely ineffective.This provocative book is the first study to provide a picture of US involvement in drug control from its inception to the present day. Its wide-ranging scope makes it of interest not only to scholars of diplomatic history, US foreign Policy and international relations, but also to anyone concerned by the universal growth of the illicit drug problem.
Publisher: A&C Black
ISBN: 9780826458131
Category : Political Science
Languages : en
Pages : 264
Book Description
The United States and International Drug Control, 1909-1997 charts the US quest to internationalize the doctrine of drug prohibition. The study reveals the origins, motivation and methodologies as well as the recurring contradictions and inconsistencies present within the US overseas fight against the production, manufacture, trafficking and use of certain psychoactive substances. Drawing on extensive historical materials, David Bewley-Taylor uses the international career of America's first Drug Czar, Harry J. Anslinger, to explore how the US successfully exploited hegemonic superiority in 1945 to influence the philosophy of the multilateral drug control system operated by the United Nations.More than a purely historical study, the book employs an interdisciplinary approach to understanding the development, perpetuation and consequences of a US driven multilateral drug control system. Examining the contemporary UN drug control framework, the author argues that international legislation is largely ineffective.This provocative book is the first study to provide a picture of US involvement in drug control from its inception to the present day. Its wide-ranging scope makes it of interest not only to scholars of diplomatic history, US foreign Policy and international relations, but also to anyone concerned by the universal growth of the illicit drug problem.
History of Drug Containers and Their Labels
Author: George B. Griffenhagen
Publisher: Amer. Inst. History of Pharmacy
ISBN: 9780931292262
Category : Medical
Languages : en
Pages : 164
Book Description
Publisher: Amer. Inst. History of Pharmacy
ISBN: 9780931292262
Category : Medical
Languages : en
Pages : 164
Book Description
Pain Management and the Opioid Epidemic
Author: National Academies of Sciences, Engineering, and Medicine
Publisher: National Academies Press
ISBN: 0309459575
Category : Medical
Languages : en
Pages : 483
Book Description
Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016. As part of this plan, the FDA asked the National Academies of Sciences, Engineering, and Medicine to convene a committee to update the state of the science on pain research, care, and education and to identify actions the FDA and others can take to respond to the opioid epidemic, with a particular focus on informing FDA's development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.
Publisher: National Academies Press
ISBN: 0309459575
Category : Medical
Languages : en
Pages : 483
Book Description
Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016. As part of this plan, the FDA asked the National Academies of Sciences, Engineering, and Medicine to convene a committee to update the state of the science on pain research, care, and education and to identify actions the FDA and others can take to respond to the opioid epidemic, with a particular focus on informing FDA's development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.
The Drug Legalization Debate
Author: James A. Inciardi
Publisher: SAGE
ISBN: 9780761906902
Category : Law
Languages : en
Pages : 196
Book Description
This completely revised and updated secong edition of the Drug Legalization Debate continues to address, and offer alternatives to, the major issues.
Publisher: SAGE
ISBN: 9780761906902
Category : Law
Languages : en
Pages : 196
Book Description
This completely revised and updated secong edition of the Drug Legalization Debate continues to address, and offer alternatives to, the major issues.
American Drug Index
Author:
Publisher:
ISBN:
Category : Drugs
Languages : en
Pages : 1080
Book Description
Publisher:
ISBN:
Category : Drugs
Languages : en
Pages : 1080
Book Description
Making Medicines Affordable
Author: National Academies of Sciences, Engineering, and Medicine
Publisher: National Academies Press
ISBN: 0309468086
Category : Medical
Languages : en
Pages : 235
Book Description
Thanks to remarkable advances in modern health care attributable to science, engineering, and medicine, it is now possible to cure or manage illnesses that were long deemed untreatable. At the same time, however, the United States is facing the vexing challenge of a seemingly uncontrolled rise in the cost of health care. Total medical expenditures are rapidly approaching 20 percent of the gross domestic product and are crowding out other priorities of national importance. The use of increasingly expensive prescription drugs is a significant part of this problem, making the cost of biopharmaceuticals a serious national concern with broad political implications. Especially with the highly visible and very large price increases for prescription drugs that have occurred in recent years, finding a way to make prescription medicinesâ€"and health care at largeâ€"more affordable for everyone has become a socioeconomic imperative. Affordability is a complex function of factors, including not just the prices of the drugs themselves, but also the details of an individual's insurance coverage and the number of medical conditions that an individual or family confronts. Therefore, any solution to the affordability issue will require considering all of these factors together. The current high and increasing costs of prescription drugsâ€"coupled with the broader trends in overall health care costsâ€"is unsustainable to society as a whole. Making Medicines Affordable examines patient access to affordable and effective therapies, with emphasis on drug pricing, inflation in the cost of drugs, and insurance design. This report explores structural and policy factors influencing drug pricing, drug access programs, the emerging role of comparative effectiveness assessments in payment policies, changing finances of medical practice with regard to drug costs and reimbursement, and measures to prevent drug shortages and foster continued innovation in drug development. It makes recommendations for policy actions that could address drug price trends, improve patient access to affordable and effective treatments, and encourage innovations that address significant needs in health care.
Publisher: National Academies Press
ISBN: 0309468086
Category : Medical
Languages : en
Pages : 235
Book Description
Thanks to remarkable advances in modern health care attributable to science, engineering, and medicine, it is now possible to cure or manage illnesses that were long deemed untreatable. At the same time, however, the United States is facing the vexing challenge of a seemingly uncontrolled rise in the cost of health care. Total medical expenditures are rapidly approaching 20 percent of the gross domestic product and are crowding out other priorities of national importance. The use of increasingly expensive prescription drugs is a significant part of this problem, making the cost of biopharmaceuticals a serious national concern with broad political implications. Especially with the highly visible and very large price increases for prescription drugs that have occurred in recent years, finding a way to make prescription medicinesâ€"and health care at largeâ€"more affordable for everyone has become a socioeconomic imperative. Affordability is a complex function of factors, including not just the prices of the drugs themselves, but also the details of an individual's insurance coverage and the number of medical conditions that an individual or family confronts. Therefore, any solution to the affordability issue will require considering all of these factors together. The current high and increasing costs of prescription drugsâ€"coupled with the broader trends in overall health care costsâ€"is unsustainable to society as a whole. Making Medicines Affordable examines patient access to affordable and effective therapies, with emphasis on drug pricing, inflation in the cost of drugs, and insurance design. This report explores structural and policy factors influencing drug pricing, drug access programs, the emerging role of comparative effectiveness assessments in payment policies, changing finances of medical practice with regard to drug costs and reimbursement, and measures to prevent drug shortages and foster continued innovation in drug development. It makes recommendations for policy actions that could address drug price trends, improve patient access to affordable and effective treatments, and encourage innovations that address significant needs in health care.
American Pharmacy (1852-2002)
Author: Gregory Higby
Publisher: Amer. Inst. History of Pharmacy
ISBN: 9780931292392
Category : Medical
Languages : en
Pages : 148
Book Description
Essays reprinted from the Journal of the American Pharmaceutical Association series commemorating the sesquicentennial of the American Pharmaceutical Association.
Publisher: Amer. Inst. History of Pharmacy
ISBN: 9780931292392
Category : Medical
Languages : en
Pages : 148
Book Description
Essays reprinted from the Journal of the American Pharmaceutical Association series commemorating the sesquicentennial of the American Pharmaceutical Association.
An Analytic Assessment of U.S. Drug Policy
Author: David Boyum
Publisher: A E I Press
ISBN:
Category : Law
Languages : en
Pages : 158
Book Description
This book concludes that AmericaOs drug policy should be reoriented in several ways to be more effective.
Publisher: A E I Press
ISBN:
Category : Law
Languages : en
Pages : 158
Book Description
This book concludes that AmericaOs drug policy should be reoriented in several ways to be more effective.